Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2026-01-02 @ 7:18 AM
Study NCT ID:
NCT02577003
Status:
COMPLETED
Last Update Posted:
2018-09-04
First Post:
2015-10-14
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Double-blind Ipragliflozin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Sitagliptin (MK-0431J-843)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-11-09
Start Date Type:
None
Primary Completion Date:
2016-11-25
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-25
Completion Date Type:
ACTUAL
First Submit Date:
2015-10-14
First Submit QC Date:
None
Study First Post Date:
2015-10-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-02-07
Results First Submit QC Date:
None
Results First Post Date:
2018-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-08-03
Last Update Post Date:
2018-09-04
Last Update Post Date Type:
ACTUAL